Olaparib
(UPDATE) Niraparib
Mirvetuximab Soravtasine-gynx (Elahere)
Trametinib
Foundation for Women's Cancer
Ovarian Cancer Research Fund Alliance
NCCN Guidelines for Patients®
CancerCare